ATE451919T1 - Hydrochinon- ansamycinen in der behandlung von gastrointestinalen stromatumoren - Google Patents
Hydrochinon- ansamycinen in der behandlung von gastrointestinalen stromatumorenInfo
- Publication number
- ATE451919T1 ATE451919T1 AT06787067T AT06787067T ATE451919T1 AT E451919 T1 ATE451919 T1 AT E451919T1 AT 06787067 T AT06787067 T AT 06787067T AT 06787067 T AT06787067 T AT 06787067T AT E451919 T1 ATE451919 T1 AT E451919T1
- Authority
- AT
- Austria
- Prior art keywords
- hydroquinone
- ansamycines
- tumors
- gastrointestinal
- stream
- Prior art date
Links
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 title abstract 5
- 206010028980 Neoplasm Diseases 0.000 title abstract 2
- 230000002496 gastric effect Effects 0.000 title 1
- AZQWKYJCGOJGHM-UHFFFAOYSA-N 1,4-benzoquinone Chemical compound O=C1C=CC(=O)C=C1 AZQWKYJCGOJGHM-UHFFFAOYSA-N 0.000 abstract 3
- 239000002253 acid Substances 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D225/00—Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom
- C07D225/04—Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D225/06—Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems condensed with one six-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Hematology (AREA)
- Pulmonology (AREA)
- Diabetes (AREA)
- Immunology (AREA)
- Oncology (AREA)
- Obesity (AREA)
- Child & Adolescent Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Saccharide Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11/180,314 US20060019941A1 (en) | 2003-12-23 | 2005-07-13 | Analogs of benzoquinone-containing ansamycins and methods of use thereof |
| PCT/US2006/027113 WO2007009007A2 (en) | 2005-07-13 | 2006-07-13 | Methods of treatment using hydroquinone ansamycins |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE451919T1 true ATE451919T1 (de) | 2010-01-15 |
Family
ID=37637939
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT06787067T ATE451919T1 (de) | 2005-07-13 | 2006-07-13 | Hydrochinon- ansamycinen in der behandlung von gastrointestinalen stromatumoren |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20060019941A1 (de) |
| EP (1) | EP1904057B1 (de) |
| JP (1) | JP2009501234A (de) |
| KR (1) | KR20080030093A (de) |
| CN (1) | CN101267816A (de) |
| AT (1) | ATE451919T1 (de) |
| AU (1) | AU2006268196A1 (de) |
| BR (1) | BRPI0612870A2 (de) |
| CA (1) | CA2612506A1 (de) |
| DE (1) | DE602006011161D1 (de) |
| ES (1) | ES2337397T3 (de) |
| IL (1) | IL188355A0 (de) |
| MX (1) | MX2007016469A (de) |
| NO (1) | NO20080304L (de) |
| WO (1) | WO2007009007A2 (de) |
| ZA (1) | ZA200800906B (de) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2004309395C1 (en) | 2003-12-23 | 2012-10-04 | Infinity Discovery, Inc. | Analogs of benzoquinone-containing ansamycins for the treatment of cancer |
| WO2006098761A2 (en) * | 2005-03-11 | 2006-09-21 | The Regents Of The University Of Colorado | Hsp90 inhibitors, methods of making and uses therefor |
| US20100279994A1 (en) * | 2005-06-21 | 2010-11-04 | Inifinity Discovery, Inc. | Ansamycin Formulations and Methods of Use Thereof |
| FR2907453B1 (fr) * | 2006-10-24 | 2008-12-26 | Sanofi Aventis Sa | Nouveaux derives du fluorene,compositions les contenant et utilisation |
| PE20081506A1 (es) * | 2006-12-12 | 2008-12-09 | Infinity Discovery Inc | Formulaciones de ansamicina |
| WO2008128063A1 (en) * | 2007-04-12 | 2008-10-23 | Infinity Discovery, Inc. | Hydroquinone ansamycin formulations |
| WO2009026548A1 (en) | 2007-08-23 | 2009-02-26 | The Regents Of The University Of Colorado | Hsp90 inhibitors with modified toxicity |
| US20090258869A1 (en) * | 2008-02-08 | 2009-10-15 | The Regents Of The University Of California | Methods and compounds for treatment or prevention of substance-related disorders |
| AU2009283157B2 (en) * | 2008-08-21 | 2015-02-26 | Alvine Pharmaceuticals, Inc. | Formulation for oral administration of proteins |
| KR20110090925A (ko) * | 2008-10-15 | 2011-08-10 | 인피니티 파마슈티컬스, 인코포레이티드 | 안사마이신 하이드로퀴논 조성물 |
| WO2010135426A1 (en) * | 2009-05-19 | 2010-11-25 | Infinity Pharmaceuticals, Inc. | Methods of treating liposarcoma |
| AR077405A1 (es) | 2009-07-10 | 2011-08-24 | Sanofi Aventis | Derivados del indol inhibidores de hsp90, composiciones que los contienen y utilizacion de los mismos para el tratamiento del cancer |
| FR2949467B1 (fr) | 2009-09-03 | 2011-11-25 | Sanofi Aventis | Nouveaux derives de 5,6,7,8-tetrahydroindolizine inhibiteurs d'hsp90, compositions les contenant et utilisation |
| US8945627B2 (en) | 2011-05-05 | 2015-02-03 | Wisconsin Alumni Research Foundation | Micelles for the solubilization of gossypol |
| US9603829B2 (en) | 2011-11-14 | 2017-03-28 | The Regents Of The University Of Colorado, A Body Corporate | HSP90 inhibitors with modified toxicity |
| US10682415B2 (en) | 2013-07-22 | 2020-06-16 | Wisconsin Alumni Research Foundation | Thermogel formulation for combination drug delivery |
| EA036496B1 (ru) | 2014-05-01 | 2020-11-17 | Ионис Фармасьютикалз, Инк. | Конъюгированные олигонуклеотиды для модулирования экспрессии фактора комплемента b |
| JP6948708B2 (ja) * | 2015-06-19 | 2021-10-13 | センチュリオン バイオファーマ コーポレイション | 薬物制御放出のための送達系 |
| CN114259564B (zh) * | 2021-11-30 | 2023-03-14 | 清华大学 | Hsp90抑制剂阻碍stat3线粒体转运和治疗哮喘的新应用 |
| CN115227692A (zh) * | 2022-09-05 | 2022-10-25 | 中国医学科学院基础医学研究所 | Reblastatin在制备治疗慢性惊厥的药物中的用途 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4261989A (en) * | 1979-02-19 | 1981-04-14 | Kaken Chemical Co. Ltd. | Geldanamycin derivatives and antitumor drug |
| GB2106111B (en) * | 1981-09-17 | 1985-11-06 | Takeda Chemical Industries Ltd | Macbecin derivatives and their production |
| US4762857A (en) * | 1986-05-30 | 1988-08-09 | E. I. Du Pont De Nemours And Company | Trehalose as stabilizer and tableting excipient |
| CA2127457A1 (en) * | 1992-01-06 | 1993-07-22 | Walter P. Cullen | Process and uses for 4,5-dihydrogeldanamycin and its hydroquinone |
| US5387584A (en) * | 1993-04-07 | 1995-02-07 | Pfizer Inc. | Bicyclic ansamycins |
| JP2794342B2 (ja) * | 1993-06-29 | 1998-09-03 | ファイザー・インク． | 抗癌遺伝子剤および抗癌剤としてのアンサマイシン誘導体 |
| US5932566A (en) * | 1994-06-16 | 1999-08-03 | Pfizer Inc. | Ansamycin derivatives as antioncogene and anticancer agents |
| DK1373215T3 (da) * | 2001-03-30 | 2006-11-13 | Us Health | Gelanamycinderivater egnet til behandling af cancer |
| US6872715B2 (en) * | 2001-08-06 | 2005-03-29 | Kosan Biosciences, Inc. | Benzoquinone ansamycins |
| AU2002330998A1 (en) * | 2001-08-06 | 2003-02-24 | Kosan Biosciences, Inc. | Benzoquinone ansamycins |
| WO2003066005A2 (en) * | 2002-02-08 | 2003-08-14 | Conforma Therapeutics Corporation | Ansamycins having improved pharmacological and biological properties |
| AU2004309395C1 (en) * | 2003-12-23 | 2012-10-04 | Infinity Discovery, Inc. | Analogs of benzoquinone-containing ansamycins for the treatment of cancer |
| WO2006098761A2 (en) * | 2005-03-11 | 2006-09-21 | The Regents Of The University Of Colorado | Hsp90 inhibitors, methods of making and uses therefor |
-
2005
- 2005-07-13 US US11/180,314 patent/US20060019941A1/en not_active Abandoned
-
2006
- 2006-07-13 ES ES06787067T patent/ES2337397T3/es active Active
- 2006-07-13 ZA ZA200800906A patent/ZA200800906B/xx unknown
- 2006-07-13 BR BRPI0612870-0A patent/BRPI0612870A2/pt not_active IP Right Cessation
- 2006-07-13 DE DE602006011161T patent/DE602006011161D1/de active Active
- 2006-07-13 WO PCT/US2006/027113 patent/WO2007009007A2/en not_active Ceased
- 2006-07-13 CA CA002612506A patent/CA2612506A1/en not_active Abandoned
- 2006-07-13 AT AT06787067T patent/ATE451919T1/de not_active IP Right Cessation
- 2006-07-13 KR KR1020087003410A patent/KR20080030093A/ko not_active Withdrawn
- 2006-07-13 MX MX2007016469A patent/MX2007016469A/es not_active Application Discontinuation
- 2006-07-13 CN CNA2006800335526A patent/CN101267816A/zh active Pending
- 2006-07-13 EP EP06787067A patent/EP1904057B1/de active Active
- 2006-07-13 JP JP2008521582A patent/JP2009501234A/ja active Pending
- 2006-07-13 AU AU2006268196A patent/AU2006268196A1/en not_active Abandoned
-
2007
- 2007-12-24 IL IL188355A patent/IL188355A0/en unknown
-
2008
- 2008-01-16 NO NO20080304A patent/NO20080304L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| MX2007016469A (es) | 2008-04-22 |
| AU2006268196A1 (en) | 2007-01-18 |
| ZA200800906B (en) | 2009-07-29 |
| JP2009501234A (ja) | 2009-01-15 |
| EP1904057A2 (de) | 2008-04-02 |
| KR20080030093A (ko) | 2008-04-03 |
| DE602006011161D1 (de) | 2010-01-28 |
| CN101267816A (zh) | 2008-09-17 |
| BRPI0612870A2 (pt) | 2010-11-30 |
| IL188355A0 (en) | 2008-08-07 |
| EP1904057B1 (de) | 2009-12-16 |
| US20060019941A1 (en) | 2006-01-26 |
| WO2007009007A3 (en) | 2007-05-03 |
| CA2612506A1 (en) | 2007-01-18 |
| ES2337397T3 (es) | 2010-04-23 |
| WO2007009007A2 (en) | 2007-01-18 |
| NO20080304L (no) | 2008-02-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20080304L (no) | Behandlingsmetoder ved bruk av hydrokinon-ansamyciner | |
| NO20062707L (no) | Analoger av benzokinon-inneholdende ansamyciner for behandling av kreft | |
| SE0303180D0 (sv) | Novel compounds | |
| SE0302232D0 (sv) | Novel Compounds | |
| EA201001371A1 (ru) | Конденсированные пиримидиноновые соединения как модуляторы trpv3 | |
| EA201071243A1 (ru) | Комбинированные композиции для лечения болезни альцгеймера и родственных заболеваний зонизамидом и акампросатом | |
| EA201001143A1 (ru) | Активаторы прокаспаз "исполнителей" 3, 6 и 7 | |
| EA201071045A1 (ru) | Соединения оксадиазоантрацена для лечения диабета | |
| CY1109985T1 (el) | Αναστολεις πρωτεασωματος και μεθοδοι χρησης αυτων | |
| TW200730515A (en) | N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase | |
| EA201070988A1 (ru) | Противовирусные терапевтические средства | |
| ATE432072T1 (de) | Verwendung von adapalen zur behandlung dermatologischer erkrankungen | |
| EA201190217A1 (ru) | Замещенные 2-ацетамидо-5-арил-1,2,4-триазолоны и их применение | |
| BRPI0519265A2 (pt) | composiÇÕes incluindo ferro | |
| NO20090623L (no) | Forbindelser for behandling av proliferative lidelser | |
| SE0301010D0 (sv) | Novel compounds | |
| TW200612892A (en) | Novel compounds | |
| CY1110318T1 (el) | Παραγωγα φαινοξυοξικου οξεος | |
| IL217623A (en) | Amino-carbonyl-boron compound is converted | |
| ATE411280T1 (de) | Phenoxyessigsäure-derivate zur behandlung von störungen der atemwege | |
| WO2008024304A3 (en) | Compounds for treatment of proliferative disorders | |
| EA201190004A1 (ru) | Конденсированные имидазол карбоксамиды в качестве модуляторов trpv3 | |
| CY1109569T1 (el) | Υποκατεστημενα παραγωγα κυκλοεξανο-1,4-διαμινης | |
| NO20076405L (no) | Anvendelse av 24-nor-UDCA | |
| ATE542536T1 (de) | 3-ä4-(dibenzoäb,füä1,4üoxazepin-11-yl)-piperazi - 1-ylü-2,2-dimethyl propansäure zur verwendung in der behandlung von schlafstörungen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |